Dr. Mahsa Abdollahi, MD

Dr. Abdollahi practices at Advanced Dermatology of San Clemente Inc in Dana Point, California.

Dr. Abdollahi's NPI, 1043445554, was assigned on May 28, 2009. Dr. Abdollahi graduated from UC Irvine School of Medicine in 2008. Dr. Abdollahi holds California license A124501.

Dr. Abdollahi's primary practice is Advanced Dermatology of San Clemente Inc, at 34213 Pacific Coast Hwy, Dana Point, CA 92629 in Orange County. The practice phone is (949) 248-4547.

Dr. Abdollahi's primary practice is Advanced Dermatology of San Clemente Inc in Dana Point, California. The medical group on file is Skin Cancer and Reconstructive Surgery (SCARS) Center. Dmand AI also links Dr. Abdollahi to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdollahi practices. Vendor and product names are available with a free account.

Dermatopathology is Dr. Abdollahi's primary specialty in the NPI Registry, under taxonomy code 207ND0900X. Dr. Abdollahi is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Abdollahi's licenses on file in 3 states: California, Colorado and Minnesota.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, itchy rashes and psoriasis among the conditions Dr. Abdollahi treats.

CMS data shows 16,499 Medicare services from Dr. Abdollahi across 29 procedure codes in 2024, for 1,187 Medicare patients. Medicare paid $608,980 for them. Every service was in an office.

CMS counts 1,187 Medicare patients who saw Dr. Abdollahi in 2024. The largest group is 65 to 74, with 557 patients. 75% of them have high cholesterol, and 60% have high blood pressure. 1% are also on Medicaid. Their average risk score is 0.91, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Abdollahi's median patient age at 67, with 55% women.

In 2024, Dr. Abdollahi wrote 683 Medicare Part D claims for 292 patients. 94% of them were for generic drugs. CMS names the drug for 563 of them, across 13 drugs with 11 or more claims each, at $52,362 in total drug cost. In 2023, CMS named 448 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Abdollahi for performance year 2024, reported as part of a group. Dr. Abdollahi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abdollahi as offering telehealth. CMS counts 435 procedures of removal or shaving of skin growth by Dr. Abdollahi, more than 95% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 206 general payments to Dr. Abdollahi from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Pfizer Inc. paid the most, $727.

Dmand AI lists 1 award for Dr. Abdollahi, most recently CMS Stage 1 EHR in 2013.

Dr. Abdollahi graduated from UC Irvine School of Medicine in 2008.

Dr. Abdollahi is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.